MAPT and Alzheimer disease: Patients with AD experience a set of biological and pathological changes in their brain, with the two most common hallmarks being amyloid-beta plaques and neurofibrillary tangles composed of abnormally accumulated amyloid-beta peptides and hyperphosphorylated tau proteins, respectively2.